Kolesnikoff, N.Chen, C.-H.Samuel, M.S.2022-05-122022-05-122022Clinical Science, 2022; 136(5):361-3770143-52211470-8736https://hdl.handle.net/2440/135072Solid tumours are composed of cancer cells characterised by genetic mutations that underpin the disease, but also contain a suite of genetically normal cells and the extracellular matrix (ECM). These two latter components are constituents of the tumour microenvironment (TME), and are key determinants of tumour biology and thereby the outcomes for patients. The tumour ECM has been the subject of intense research over the past two decades, revealing key biochemical and mechanobiological principles that underpin its role in tumour cell proliferation and survival. However, the ECM also strongly influences the genetically normal immune cells within the microenvironment, regulating not only their proliferation and survival, but also their differentiation and access to tumour cells. Here we review recent advances in our knowledge of how the ECM regulates the tumour immune microenvironment and vice versa, comparing normal skin wound healing to the pathological condition of tumour progression.en© 2022 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY).extracellular matrixinfiltrationstromatumour immunitywound healingJournal article10.1042/cs202106792022-05-122-s2.0-85126076131605021Kolesnikoff, N. [0000-0003-4314-4779]Samuel, M.S. [0000-0001-7880-6379]